Rising Incidence Of Traumatic Brain Injuries Fuels Growth Of External Ventricular Drain Market Is Supporting Development Across The External Ventricular Drain Market
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
By 2030, How Much Growth In Market Size Is Expected For The External Ventricular Drain Market?
The market for external ventricular drains has experienced robust expansion over recent years. Projections indicate a rise from $4.99 billion in 2025 to $5.33 billion in 2026 for this market, reflecting a compound annual growth rate (CAGR) of 6.7%. Historically, this growth is primarily due to factors such as a rise in the incidence of traumatic brain injury, an increase in cases of intracranial hemorrhage, the expanding prevalence of hydrocephalus, the proliferation of neurosurgical care facilities, and the greater implementation of critical care monitoring practices.
The external ventricular drain market size is projected to experience substantial expansion over the next few years. This market is anticipated to reach $6.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. The growth expected during the forecast period can be attributed to the increasing burden of neurological disorders, a rising demand for advanced neurocritical care, growing investments in neurosurgery infrastructure, enhanced awareness of intracranial pressure management, and expanding access to specialty neurological hospitals. Major trends during this forecast period include the increasing use of external ventricular drains in neurocritical care, the growing adoption of adjustable and continuous EVD systems, a heightened demand for accurate intracranial pressure management, an increasing focus on infection control in cerebrospinal fluid drainage, and the expanding utilization of EVDs in traumatic brain injury management.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15808&type=smp
Which Growth Drivers Are Expected To Support The External Ventricular Drain Market Forward?
The rising occurrence of traumatic brain injuries (TBI) is projected to stimulate the expansion of the external ventricular drain market in the future. Traumatic brain injury (TBI) describes damage to the brain resulting from an external force, potentially causing temporary or permanent impairments in cognitive, physical, and psychosocial functions. The increasing frequency of traumatic brain injuries can be linked to factors such as greater participation in contact sports, higher rates of motor vehicle accidents, and an aging demographic more susceptible to falls. TBIs have the potential to generate elevated intracranial pressure (ICP) due to swelling, hemorrhages, or the accumulation of cerebrospinal fluid (CSF), all of which can lead to further brain damage. The external ventricular drain (EVD) assists in minimizing these outcomes by draining excess CSF and consistently monitoring ICP. For example, in October 2023, as reported by the World Federation of Neurology, a UK-based organization committed to advancing neurological practice and research worldwide, over 40% of the global population experiences a neurological condition, a figure expected to almost double by 2050. Therefore, the growing incidence of traumatic brain injuries is fueling the growth of the external ventricular drain market.
How Does Segment Analysis Break Down The External Ventricular Drain Market Structure?
The external ventricular drain market covered in this report is segmented –
1) By Product: External Ventricular Drainage Set, Accessories
2) By Application: Traumatic Brain Injury, Intracranial Hemorrhage, Hydrocephalus, Other Applications
3) By End-User: Hospitals, Specialty Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By External Ventricular Drainage Set: Standard External Ventricular Drainage Set, Adjustable External Ventricular Drainage Set, Continuous External Ventricular Drainage Set
2) By Accessories: Catheters, Pressure Monitoring Devices, Drainage Bags, Connecting Tubes
What Trends Are Affecting The Growth Of The External Ventricular Drain Market?
Leading companies in the external ventricular drain market are concentrating on developing innovative solutions, such as neurocritical care devices, to enhance patient outcomes, improve procedural efficiency, and address complex neurological conditions. A neurocritical care device is a medical instrument used to monitor and manage critically ill patients with severe neurological conditions, supporting functions like intracranial pressure monitoring and cerebrospinal fluid drainage. For instance, in March 2025, Anuncia Medical Inc., a US-based neurotherapeutic device company, received FDA Breakthrough Device Designation for its ReFlow External Ventricular Drains (EVD), a novel device designed to manage brain swelling and elevated intracranial pressure. The ReFlow EVD is the first of its kind to offer a noninvasive, manual flushing mechanism to restore and maintain cerebrospinal fluid (CSF) flow. It can be operated by nurses during routine patient checks, potentially reducing ICU stays, additional surgeries, and costly EVD replacements. This designation expands Anuncia’s portfolio beyond hydrocephalus management into acute neurocritical care, enhancing patient outcomes and clinical workflows.
Which Organizations Are Involved In The External Ventricular Drain Market?
Major companies operating in the external ventricular drain market are Medtronic Plc, B. Braun SE, Integra LifeSciences, Teleflex Incorporated, Spiegelberg GmbH & Co. KG, IRRAS AB, Sophysa, Raumedic AG, Luciole Medical AG, Fuji Systems Corporation, Ad-Tech Medical Instrument Corporation, Mizuho Medical Co. Ltd., Nipro Corporation, Kaneka Corporation, Samyang Biopharmaceuticals Corporation, Neuromedex GmbH, SILMAG S.A., Tokibo Co. Ltd., Well Lead Medical Co. Ltd., Beijing Xinlingwei Technology Co. Ltd.
Access The Complete External Ventricular Drain Market Report:
https://www.thebusinessresearchcompany.com/report/external-ventricular-drain-global-market-report
Which Area Represents The Largest Portion Of The External Ventricular Drain Market?
North America was the largest region in the external ventricular drain market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the external ventricular drain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized External Ventricular Drain Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=15808&type=smp
Browse Through More Reports Similar to the Global External Ventricular Drain Market 2026, By The Business Research Company
Ventricular Fibrillation Market Report 2026
https://www.thebusinessresearchcompany.com/report/ventricular-fibrillation-global-market-report
Ventricular Assist Device Market Report 2026
https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report
Cardiac Valve Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
